On This Page Date: September 11, 2025 Time: 12:00 p.m. - 2:00 p.m. ET This webinar will provide an in-depth look at the draft ICH M13B guideline titled "Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver" that was endorsed by...

Summary Company Announcement Date: August 12, 2025 FDA Publish Date: August 12, 2025 Product Type: Medical Devices Reason for Announcement: Recall Reason Description Due to potential safety and performance concerns Company Name: Max Mobility, LLC. Brand Name: Product...

On This Page The Eco-NAMS webinar series is co-organized by the U.S. Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, Health and Environmental Sciences Institute, National Institute for Environmental Studies (Japan), and...

Delivery Method: Via Email Product: Drugs Recipient: Recipient Name Serge Milbank Confer With 81 Rivington StLondonEC2A 3AYUnited Kingdom getintouch@conferwith.io Issuing Office: Center for Drug Evaluation and Research (CDER) United States WARNING LETTERAugust 1,...

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Orange County Health Care Agency, Santa Ana, California, USA (A.H. Dratch,...